A methanolic extract of Eclipta prostrata (L.) L. decreases inflammation in a murine model of chronic allergic asthma via inhibition of the NF-kappa-B pathway

• Published in: Journal of ethnopharmacology 2024-01, Vol.318 (Pt B), p.116930-116930, Article 116930
• Main Authors: Morel, Lucas Junqueira de Freitas, Carmona, Fabio, Guimarães, Camila Carla, Moreira, Letícia Gabriela Quieroz, Leão, Patricia dos Santos, Crevelin, Eduardo José, Batah, Sabrina Setembre, Fabro, Alexandre Todorovic, França, Suzelei de Castro, Borges, Marcos de Carvalho, Pereira, Ana Maria Soares
• Format: Article
• Language: English
• Subjects: Asteraceae; Asthma; Demethylwedelolactone; Inflammation; Nuclear factor kappa-B; Wedelolactone
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2023.116930

Eclipta prostrata (L.) L. is a medicinal plant used by many ethnic groups in Brazil to treat respiratory diseases, hepatitis and the bites of venomous animals. A methanolic extract of E. prostrata (MEEP), the major components of which are wedelolactone (WED) and demethylwedelolactone (DMW), exhibited anti-inflammatory activity in acute asthma models but the effects on lung inflammation and the mechanisms of action of MEEP in a chronic asthma model are not known. To study the effects of MEEP in vivo using a chronic ovalbumin (OVA)-induced allergic asthma model in mice. The identities of WED and DMW in MEEP were confirmed and the concentrations determined by liquid chromatography and tandem mass spectrometry. Male Balb/c mice were sensitized and challenged with OVA and experimental animals were treated with MEEP (100, 250 or 500 mg/kg) while control animals were treated with dexamethasone (2 mg/kg) or normal saline. Bronchial hyperresponsiveness, total and differential cell counts in bronchoalveolar lavage (BAL), and the production of Th2 cytokines in lung homogenates were assessed. Lung inflammation and mucus production were evaluated by histological analysis while nuclear factor kappa-B (NF-κB) activation was assessed immunohistochemically. Concentrations of WED and DMW in MEEP were 5.12% and 1.04%, respectively. Treatments with MEEP (250 or 500 mg/kg) significantly decreased bronchial hyperresponsiveness, reduced total cell and eosinophil counts in BAL and IL-4 concentrations in lung homogenate, and inhibited NF-κB activation. Treatment with MEEP at 500 mg/kg reduced the level of IL-5 in lung homogenates but did not decrease IL-13 concentration or mucus production. MEEP attenuated bronchial hyperresponsiveness and decreased lung and airway inflammation in a chronic asthma model in mice. The mechanism of action involves inhibition of NF-κB activation, most likely associated with the presence of the coumestans WED and DMW. These results support the ethnopharmacological evidence for the use of E. prostrata against asthma and other respiratory inflammatory diseases. [Display omitted]